Target Name: MIR548AV
NCBI ID: G100847083
Other Name(s): MicroRNA 548av | hsa-miR-548av-5p | microRNA 548av | hsa-mir-548av | hsa-miR-548av-3p

MIR548AV: A Potential Drug Target and Biomarker

MIR548AV, a non-coding RNA molecule, has been identified as a potential drug target and biomarker in various diseases, including cancer. Its unique structure and expression pattern make it an attractive target for researchers to investigate. In this article, we will discuss the research on MIR548AV and its potential as a drug target and biomarker.

Structure and Expression

MIR548AV is a small non-coding RNA molecule, with only 29 amino acid residues. It has a characteristic stem-loop structure and is expressed in various tissues and organs, including brain, heart, liver, and cancer cells. The expression pattern of MIR548AV varies between tissues, and its expression is often higher in cancer cells compared to healthy cells.

MIR548AV has been shown to play a role in various cellular processes, including cell growth, apoptosis, and inflammation. It has been shown to promote the expression of pro-inflammatory genes, such as NLRP1, and to inhibit the expression of anti-inflammatory genes, such as PDGF1. MIR548AV has also been shown to play a role in the regulation of cell cycle progression and has been shown to promote the G1 phase and the S phase of the cell cycle.

Drug Target Potential

MIR548AV has been identified as a potential drug target due to its unique structure and expression pattern. The stem-loop region of MIR548AV has been shown to be a critical region for drug targeting, as it is involved in various cellular processes and is a common target for small molecules. Several drugs, including inhibitors of the PI3K/Akt signaling pathway and DNA-binding proteins, have been shown to interact with MIR548AV and to inhibit its activity. These drugs have been shown to have potential therapeutic benefits in various diseases, including cancer.

Biomarker Potential

MIR548AV has also been identified as a potential biomarker for several diseases, including cancer. Its unique expression pattern and involvement in cellular processes make it an attractive target for diagnostic tests. Several studies have shown that MIR548AV is overexpressed in various types of cancer, including breast, lung, and colorectal cancer. The expression of MIR548AV has also been shown to be associated with the development of cancer. These findings suggest that MIR548AV may be a useful biomarker for cancer diagnosis and treatment.

Conclusion

MIR548AV is a non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases, including cancer. Its unique structure and expression pattern make it an attractive target for researchers to investigate. Further studies are needed to fully understand the role of MIR548AV as a drug target and biomarker.

Protein Name: MicroRNA 548av

More Common Targets

MIR548AW | MIR548AX | MIR548AY | MIR548AZ | MIR548B | MIR548BA | MIR548BC | MIR548C | MIR548D1 | MIR548D2 | MIR548E | MIR548F1 | MIR548F2 | MIR548F3 | MIR548F4 | MIR548F5 | MIR548G | MIR548H1 | MIR548H2 | MIR548H3 | MIR548H4 | MIR548H5 | MIR548I1 | MIR548I2 | MIR548I3 | MIR548I4 | MIR548J | MIR548K | MIR548L | MIR548M | MIR548N | MIR548O | MIR548O2 | MIR548P | MIR548Q | MIR548S | MIR548T | MIR548U | MIR548V | MIR548W | MIR548X | MIR548Y | MIR549A | MIR550A1 | MIR550A2 | MIR550A3 | MIR550B1 | MIR550B2 | MIR551A | MIR551B | MIR552 | MIR553 | MIR554 | MIR555 | MIR556 | MIR557 | MIR5571 | MIR5572 | MIR5579 | MIR558 | MIR5580 | MIR5581 | MIR5582 | MIR5583-1 | MIR5584 | MIR5585 | MIR5586 | MIR5587 | MIR5588 | MIR5589 | MIR559 | MIR5590 | MIR5591 | MIR561 | MIR562 | MIR563 | MIR564 | MIR566 | MIR567 | MIR568 | MIR5680 | MIR5681A | MIR5681B | MIR5682 | MIR5683 | MIR5684 | MIR5685 | MIR5687 | MIR5688 | MIR5689 | MIR569 | MIR5690 | MIR5691 | MIR5692A1 | MIR5692A2 | MIR5692B | MIR5692C1 | MIR5692C2 | MIR5693 | MIR5694